{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:55:33Z","timestamp":1790103333539,"version":"4.0.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1097\/dcr.0000000000000057","type":"journal-article","created":{"date-parts":[[2014,3,7]],"date-time":"2014-03-07T12:10:25Z","timestamp":1394194225000},"page":"423-431","source":"Crossref","is-referenced-by-count":40,"title":["Long-term Effects of Chemoradiotherapy for Anal Cancer in Patients With HIV Infection"],"prefix":"10.1097","volume":"57","author":[{"given":"Ingeborg B.","family":"Fraunholz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Haberl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Klauke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus M.","family":"R\u00f6del","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210119","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","article-title":"Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.","volume":"14","author":"Flam","year":"1996","journal-title":"J Clin Oncol"},{"key":"R3-3-20210119","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","article-title":"Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.","volume":"15","author":"Bartelink","year":"1997","journal-title":"J Clin Oncol"},{"key":"R4-3-20210119","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"key":"R5-3-20210119","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","article-title":"Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I).","volume":"102","author":"Northover","year":"2010","journal-title":"Br J Cancer"},{"key":"R6-3-20210119","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/cncr.27825","article-title":"United Kingdom Coordinating Committee on Cancer Research Anal Cancer Trial Working Party. Prognostic factors for recurrence and survival in anal cancer: generating hypotheses from the mature outcomes of the first United Kingdom Coordinating Committee on Cancer Research Anal Cancer Trial (ACT I).","volume":"119","author":"Glynne-Jones","year":"2013","journal-title":"Cancer"},{"key":"R7-3-20210119","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracilmitomycin versus fluorouracilcisplatin.","volume":"30","author":"Gunderson","year":"2012","journal-title":"J Clin Oncol"},{"key":"R8-3-20210119","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2011.35.4837","article-title":"Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial.","volume":"30","author":"Peiffert","year":"2012","journal-title":"J Clin Oncol"},{"key":"R9-3-20210119","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1148\/radiology.193.1.8090901","article-title":"Tolerance of patients with human immunodeficiency virus and anal carcinoma to treatment with combined chemotherapy and radiation therapy.","volume":"193","author":"Holland","year":"1994","journal-title":"Radiology"},{"key":"R10-3-20210119","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1007\/BF02234605","article-title":"HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients.","volume":"44","author":"Kim","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"R11-3-20210119","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/BF02234322","article-title":"Outcome analysis of HIV-positive patients with anal squamous cell carcinoma.","volume":"44","author":"Place","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"R12-3-20210119","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/BF02052589","article-title":"Squamous-cell carcinoma of the anus in HIV-positive patients.","volume":"37","author":"Chadha","year":"1994","journal-title":"Dis Colon Rectum"},{"key":"R13-3-20210119","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0360-3016(96)00596-2","article-title":"Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal.","volume":"37","author":"Peddada","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R14-3-20210119","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0959-8049(00)00009-5","article-title":"Treatment of HIV-associated invasive anal cancer with combined chemoradiation.","volume":"36","author":"Cleator","year":"2000","journal-title":"Eur J Cancer"},{"key":"R15-3-20210119","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0360-3016(98)00528-8","article-title":"The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer.","volume":"44","author":"Hoffman","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R17-3-20210119","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3816\/CCC.2010.n.035","article-title":"Efficacy and toxicity of chemoradiation in the treatment of HIV-associated anal cancer.","volume":"9","author":"Hauerstock","year":"2010","journal-title":"Clin Colorectal Cancer"},{"key":"R18-3-20210119","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijrobp.2008.10.046","article-title":"Outcomes of chemoradiotherapy with 5-fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.","volume":"75","author":"Seo","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R19-3-20210119","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijrobp.2006.03.049","article-title":"Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities.","volume":"66","author":"Edelman","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R20-3-20210119","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1007\/s10350-004-0910-7","article-title":"Anal carcinomas in HIV-positive patients: high-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy.","volume":"48","author":"Blazy","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"R21-3-20210119","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s10350-004-0584-1","article-title":"Outcome of HIV-infected patients with invasive squamous-cell carcinoma of the anal canal in the era of highly active antiretroviral therapy.","volume":"47","author":"Stadler","year":"2004","journal-title":"Dis Colon Rectum"},{"key":"R22-3-20210119","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1200\/JCO.2007.15.2348","article-title":"HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy.","volume":"26","author":"Oehler-Janne","year":"2008","journal-title":"J Clin Oncol"},{"key":"R23-3-20210119","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10350-007-9154-7","article-title":"Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy.","volume":"51","author":"Wexler","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"R24-3-20210119","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/DCR.0b013e31819eefa6","article-title":"HIV and anal cancer outcomes: a single institutions experience.","volume":"52","author":"Hogg","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"R25-3-20210119","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/DCR.0b013e3182137de9","article-title":"Anal carcinoma in HIV-infected patients in the era of antiretroviral therapy: a comparative study.","volume":"54","author":"Munoz-Bongrand","year":"2011","journal-title":"Dis Colon Rectum"},{"key":"R26-3-20210119","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00003088-200544020-00001","article-title":"Interactions between antiretrovirals and antineoplastic drug therapy.","volume":"44","author":"Antoniou","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"R27-3-20210119","first-page":"5230","article-title":"The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells.","volume":"62","author":"Pajonk","year":"2002","journal-title":"Cancer Res"},{"key":"R29-3-20210119","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1200\/JCO.2007.15.2355","article-title":"Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer.","volume":"26","author":"Brunner","year":"2008","journal-title":"J Clin Oncol"},{"key":"R30-3-20210119","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/0959-8049(92)90079-H","article-title":"Changes of lymphocyte subsets after local irradiation for early stage breast cancer and seminoma testis: long-term increase of activated (HLA-DR) T cells and decrease of naive (CD4-CD45R) T lymphocytes.","volume":"28A","author":"De Ruysscher","year":"1992","journal-title":"Eur J Cancer"},{"key":"R31-3-20210119","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1634\/stemcells.18-1-10","article-title":"T-cell immunodeficiency following cytotoxic antineoplastic therapy: a review.","volume":"18","author":"Mackall","year":"2000","journal-title":"Stem Cells"},{"key":"R33-3-20210119","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.ijrobp.2009.03.060","article-title":"Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for invasive anal carcinoma in human immunodeficiency virus-positive patients receiving highly active antiretroviral therapy.","volume":"76","author":"Fraunholz","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R34-3-20210119","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s10350-004-6677-z","article-title":"Detrimental immunologic effects of preoperative chemoradiotherapy in advanced rectal cancer.","volume":"46","author":"Wichmann","year":"2003","journal-title":"Dis Colon Rectum"},{"key":"R35-3-20210119","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/QAD.0b013e32833a3967","article-title":"AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study.","volume":"24","author":"Buchacz","year":"2010","journal-title":"AIDS"}],"container-title":["Diseases of the Colon & Rectum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DCR.0000000000000057","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:51:29Z","timestamp":1620949889000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003453-201404000-00003"}},"subtitle":["Oncological Outcomes, Immunological Status, and the Clinical Course of the HIV Disease"],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/dcr.0000000000000057","relation":{},"ISSN":["0012-3706"],"issn-type":[{"value":"0012-3706","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}